Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide

  • Vaxman I
  • Eaton J
  • Lee H
  • et al.
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Herein we present a patient that underwent a liver transplant due to primary biliary cholangitis (PBC) and after 9 years developed multiple myeloma. Following the cessation of mycophenolate mofetil and 2 weeks after lenalidomide treatment was started, the patient experienced acute cellular rejection. The patient recovered after treatment with corticosteroids, resumption of mycophenolate mofetil, and cessation of lenalidomide. Lenalidomide-associated allograft rejection has been reported in other organs. However, this is the first case report of liver rejection induced by lenalidomide.

Cite

CITATION STYLE

APA

Vaxman, I., Eaton, J., Lee, H. E., & Gertz, M. A. (2020). Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide. Case Reports in Transplantation, 2020, 1–4. https://doi.org/10.1155/2020/8894922

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free